Incyte (INCY) Long-Term Deferred Tax (2017 - 2026)

Incyte (INCY) posted Long-Term Deferred Tax of $452.5 million for Q1 2026, down 12.18% on a QoQ basis from $515.3 million in Q4 2025, and down 41.15% year-over-year from $768.9 million in Q1 2025.

Incyte (INCY) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends

Incyte's Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $452.5 million for Q1 2026.

  • Quarterly Long-Term Deferred Tax fell 41.15% year-over-year to $452.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $452.5 million (down 41.15% YoY) and the FY2025 annual result came in at $515.3 million, down 32.38% from the prior year.
  • Long-Term Deferred Tax was $452.5 million for Q1 2026 at Incyte, down from $515.3 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $768.9 million in Q1 2025 and bottomed at $426.8 million in Q3 2022.
  • A 5-year average of $579.2 million and a median of $532.5 million in 2023 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2023 — Long-Term Deferred Tax soared 37.98% — and 2026, when it plunged 41.15%.
  • Incyte's Long-Term Deferred Tax stood at $457.9 million in 2022, then surged by 37.98% to $631.9 million in 2023, then grew by 20.6% to $762.1 million in 2024, then sank by 32.38% to $515.3 million in 2025, then declined by 12.18% to $452.5 million in 2026.
  • Business Quant data shows INCY's Long-Term Deferred Tax at $452.5 million in Q1 2026, $515.3 million in Q4 2025, and $528.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 452.52 Mn
Dec 31, 2025 515.29 Mn
Sep 30, 2025 528.14 Mn
Jun 30, 2025 652.28 Mn
Mar 31, 2025 768.90 Mn
Dec 31, 2024 762.07 Mn
Sep 30, 2024 762.31 Mn
Jun 30, 2024 729.56 Mn
Mar 31, 2024 666.57 Mn
Dec 31, 2023 631.89 Mn
Sep 30, 2023 564.39 Mn
Jun 30, 2023 532.51 Mn
Mar 31, 2023 494.75 Mn
Dec 31, 2022 457.94 Mn
Sep 30, 2022 426.84 Mn
Jun 30, 2022 434.87 Mn
Mar 31, 2022 465.37 Mn
Dec 31, 2021 467.54 Mn
Dec 31, 2020 2.05 Mn
Dec 31, 2019 1.65 Mn